Efficacy, Safety and Immunogenicity of a Novel Adjuvanted Subunit Herpes Zoster Vaccine in Japanese Aged 50 Years and 70 Years and Older
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details